drugset / Trial / NCT00633152

Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections

NCT00633152

Phase 2 Completed 150 enrolled Forest Laboratories
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of complicated skin and skin structure infections in adults.

Timeline

Start
2008-02
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftaroline Other / unclassified 600 mg Intramuscular
Comparator Linezolid Other / unclassified 600 mg Intravenous
Comparator Aztreonam Small molecule 1000 mg Intravenous